Kane Biotech Announces Extension of Private Placement Offering
April 29, 2022 16:05 ET
|
Kane Biotech Inc.
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, April 29, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane...
Nuvoda Announces an Exclusive Partnership With ACWA Services Limited as Agent of Its Cutting-Edge Patented MOB™ Process Technology in the UK and Ireland
February 16, 2022 08:45 ET
|
Nuvoda
RALEIGH, N.C., Feb. 16, 2022 (GLOBE NEWSWIRE) -- Nuvoda, a research and technology firm to solve the world's water reuse issues, today announced ACWA Services Limited, a North Yorkshire UK...
Provectus Biopharmaceuticals Announces Publication of Pharmaceutical-Grade Rose Bengal’s Activity Against Gram-Positive Bacteria
January 10, 2022 06:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that preclinical research on a formulation of the Company’s pharmaceutical-grade rose bengal against...
Headworks International Announces Strategic Partnership in Ireland With Glan Agua
October 26, 2021 03:00 ET
|
Headworks International Inc.
HOUSTON, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Headworks International Inc. and Glan Agua Ltd. announced today that the companies have entered into a strategic channel partnership which will aim at...
Kane Biotech to Release Second Quarter 2021 Financial Results on August 26 – Conference Call to Follow
August 19, 2021 16:00 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Biotech Receives Decisions to Grant for Two European Patents Providing Broad Protection of coactiv+™ Technology for Wound Care, Skin Infections and Personal Care Formulations
July 29, 2021 08:00 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, July 29, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. announces that it has received two Decisions to Grant from the European Patent Office for patents covering its best-in-class...
Kane Biotech Announces Cancellation of Options and Issuance of Restricted Share Units
July 21, 2021 16:30 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, July 21, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF), (the “Company” or “Kane Biotech”), today announces that it has cancelled 8,470,555 stock options of...
Kane Biotech Announces Adoption of Performance and Restricted Share Unit Plan and Amended and Restated Stock Option Plan
June 09, 2021 16:00 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, June 09, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF), (the “Company” or “Kane Biotech”), today announced that, at the annual and special meeting of...
Kane Biotech Announces Positive Efficacy Results in STEM Pet Oral Care Clinical Trial
March 10, 2021 08:00 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, March 10, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane”), announced today that preliminary analysis of data from efficacy trials...
Kane Biotech Announces New Chairman
February 24, 2021 08:45 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), announced today current Board member Mark Nawacki will take over...